Modeling BK Virus Infection in Renal Transplant Recipients

Kidney transplant recipients require a lifelong protocol of immunosuppressive therapy to prevent graft rejection. However, these same medications leave them susceptible to opportunistic infections. One pathogen of particular concern is human polyomavirus 1, also known as BK virus (BKPyV). This virus...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicholas Myers, Dana Droz, Bruce W. Rogers, Hien Tran, Kevin B. Flores, Cliburn Chan, Stuart J. Knechtle, Annette M. Jackson, Xunrong Luo, Eileen T. Chambers, Janice M. McCarthy
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/17/1/50
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587344481353728
author Nicholas Myers
Dana Droz
Bruce W. Rogers
Hien Tran
Kevin B. Flores
Cliburn Chan
Stuart J. Knechtle
Annette M. Jackson
Xunrong Luo
Eileen T. Chambers
Janice M. McCarthy
author_facet Nicholas Myers
Dana Droz
Bruce W. Rogers
Hien Tran
Kevin B. Flores
Cliburn Chan
Stuart J. Knechtle
Annette M. Jackson
Xunrong Luo
Eileen T. Chambers
Janice M. McCarthy
author_sort Nicholas Myers
collection DOAJ
description Kidney transplant recipients require a lifelong protocol of immunosuppressive therapy to prevent graft rejection. However, these same medications leave them susceptible to opportunistic infections. One pathogen of particular concern is human polyomavirus 1, also known as BK virus (BKPyV). This virus attacks kidney tubule epithelial cells and is a direct threat to the health of the graft. Current standard of care in BK virus-infected transplant recipients is reduction in immunosuppressant therapy, to allow the patient’s immune system to control the virus. This requires a delicate balance; immune suppression must be strong enough to prevent rejection, yet weak enough to allow viral clearance. We seek to model viral and immune dynamics with the ultimate goal of applying optimal control methods to this problem. In this paper, we begin with a previously published model and make simplifying assumptions that reduce the number of parameters from 20 to 14. We calibrate our model using newly available patient data and a detailed sensitivity analysis. Numerical results for multiple patients are given to show that the newer model reflects observed dynamics well.
format Article
id doaj-art-38902c6ed8cc468fa2328be85d0640b1
institution Kabale University
issn 1999-4915
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj-art-38902c6ed8cc468fa2328be85d0640b12025-01-24T13:52:23ZengMDPI AGViruses1999-49152024-12-011715010.3390/v17010050Modeling BK Virus Infection in Renal Transplant RecipientsNicholas Myers0Dana Droz1Bruce W. Rogers2Hien Tran3Kevin B. Flores4Cliburn Chan5Stuart J. Knechtle6Annette M. Jackson7Xunrong Luo8Eileen T. Chambers9Janice M. McCarthy10Center for Research in Scientific Computation, Department of Mathematics, North Carolina State University, Raleigh, NC 27695, USACenter for Research in Scientific Computation, Department of Mathematics, North Carolina State University, Raleigh, NC 27695, USADepartment of Surgery, Duke University, Durham, NC 27710, USACenter for Research in Scientific Computation, Department of Mathematics, North Carolina State University, Raleigh, NC 27695, USACenter for Research in Scientific Computation, Department of Mathematics, North Carolina State University, Raleigh, NC 27695, USADuke Center for Human Systems Immunology, Duke University, Durham, NC 27701, USADepartment of Surgery, Duke University, Durham, NC 27710, USADepartment of Surgery, Duke University, Durham, NC 27710, USADepartment of Medicine, Duke University, Durham, NC 27710, USADepartment of Surgery, Duke University, Durham, NC 27710, USADuke Center for Human Systems Immunology, Duke University, Durham, NC 27701, USAKidney transplant recipients require a lifelong protocol of immunosuppressive therapy to prevent graft rejection. However, these same medications leave them susceptible to opportunistic infections. One pathogen of particular concern is human polyomavirus 1, also known as BK virus (BKPyV). This virus attacks kidney tubule epithelial cells and is a direct threat to the health of the graft. Current standard of care in BK virus-infected transplant recipients is reduction in immunosuppressant therapy, to allow the patient’s immune system to control the virus. This requires a delicate balance; immune suppression must be strong enough to prevent rejection, yet weak enough to allow viral clearance. We seek to model viral and immune dynamics with the ultimate goal of applying optimal control methods to this problem. In this paper, we begin with a previously published model and make simplifying assumptions that reduce the number of parameters from 20 to 14. We calibrate our model using newly available patient data and a detailed sensitivity analysis. Numerical results for multiple patients are given to show that the newer model reflects observed dynamics well.https://www.mdpi.com/1999-4915/17/1/50kidneyrenaltransplantmodelingsensitivityBKPyV
spellingShingle Nicholas Myers
Dana Droz
Bruce W. Rogers
Hien Tran
Kevin B. Flores
Cliburn Chan
Stuart J. Knechtle
Annette M. Jackson
Xunrong Luo
Eileen T. Chambers
Janice M. McCarthy
Modeling BK Virus Infection in Renal Transplant Recipients
Viruses
kidney
renal
transplant
modeling
sensitivity
BKPyV
title Modeling BK Virus Infection in Renal Transplant Recipients
title_full Modeling BK Virus Infection in Renal Transplant Recipients
title_fullStr Modeling BK Virus Infection in Renal Transplant Recipients
title_full_unstemmed Modeling BK Virus Infection in Renal Transplant Recipients
title_short Modeling BK Virus Infection in Renal Transplant Recipients
title_sort modeling bk virus infection in renal transplant recipients
topic kidney
renal
transplant
modeling
sensitivity
BKPyV
url https://www.mdpi.com/1999-4915/17/1/50
work_keys_str_mv AT nicholasmyers modelingbkvirusinfectioninrenaltransplantrecipients
AT danadroz modelingbkvirusinfectioninrenaltransplantrecipients
AT brucewrogers modelingbkvirusinfectioninrenaltransplantrecipients
AT hientran modelingbkvirusinfectioninrenaltransplantrecipients
AT kevinbflores modelingbkvirusinfectioninrenaltransplantrecipients
AT cliburnchan modelingbkvirusinfectioninrenaltransplantrecipients
AT stuartjknechtle modelingbkvirusinfectioninrenaltransplantrecipients
AT annettemjackson modelingbkvirusinfectioninrenaltransplantrecipients
AT xunrongluo modelingbkvirusinfectioninrenaltransplantrecipients
AT eileentchambers modelingbkvirusinfectioninrenaltransplantrecipients
AT janicemmccarthy modelingbkvirusinfectioninrenaltransplantrecipients